LEADER 00941nam a22002297i 4500
001 991002893479707536
008 141230s2013    bl ||||||    ||||| |fre|c
035   $ab14250226-39ule_inst
100 1 $aRimbaud, Arthur$0159565
245 10$aRimbaud livre /$cIntrodução e traduções de Augusto de Campos ; com iluminações computadorizadas de Augusto de Campos e Arnaldo Antunes
260   $aSão Paulo  :$bPerspectiva,
300   $a62 p. :$bill. ;$c21 cm
500   $aTesto orig. a fronte
700 1 $aCampos, Augusto : de$eauthor$4http://id.loc.gov/vocabulary/relators/aut$0705336
700 1 $aAntunes, Arnaldo
830  0$aSignos 
907   $a.b14250226$b02-03-16$c02-03-16
912   $a991002893479707536
945   $aLE012 848.8 RIM 6$g1$i2012000429567$lle012$o-$pE0.00$q-$rl$s-  $t0$u0$v0$w0$x0$y.i15713775$z02-03-16
996   $aRimbaud livre$91444042
997   $aUNISALENTO
998   $ale012$b02-03-16$cm$da  $e $ffre$gbl $h0$i0

LEADER 02624nam  2200625Ia 450 
001 9910966526703321
005 20200520144314.0
010   $a9781608054701
010   $a1608054705
035   $a(CKB)2670000000271397
035   $a(EBL)1058006
035   $a(OCoLC)818819310
035   $a(SSID)ssj0000914441
035   $a(PQKBManifestationID)11472063
035   $a(PQKBTitleCode)TC0000914441
035   $a(PQKBWorkID)10863981
035   $a(PQKB)11009670
035   $a(MiAaPQ)EBC1058006
035   $a(Au-PeEL)EBL1058006
035   $a(CaPaEBR)ebr10621400
035   $a(OCoLC)823743211
035   $a(DE-B1597)731054
035   $a(DE-B1597)9781608054701
035   $a(EXLCZ)992670000000271397
100   $a20121204d2012      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aHow selegiline ((-)-deprenyl) slows brain aging /$fauthored by Joseph Knoll
205   $a1st ed.
210   $a[s.l] $cBentham Science Publishers$d2012
215   $a1 online resource (161 p.)
300   $aDescription based upon print version of record.
311 08$a9781608055944 
311 08$a1608055949 
320   $aIncludes bibliographical references and indexes.
327   $aCover; Title; EUL; Contents; Foreword; Abbreviations; Keywords; Introduction; Chapter 01; Chapter 02; Chapter 03; Chapter 04; Chapter 05; Chapter 06; Chapter 07; Chapter 08; Chapter 09; Summary and Conclusion; Epilogue; References; Appendix; Author Index; Subject Index
330   $aThis e-book is a reference on Selegiline ((-)-Deprenyl) effects on the brain.  Selegiline, described in thousands of research papers, is registered in over 60 countries. At present, more than one hundred preparations containing selegiline circulate in the global market under different brand names. They are widely used in the treatment of Parkinson's disease, Alzheimer's disease, major depression and as a geroprotective / anti-aging drug.   ((-)-Deprenyl) selegiline, the first selective inhibitor of B-type MAO which, in contrast to the known MAO inhibitors, did not potentiate the effect of tyra
606   $aDepression, Mental
606   $aBrain$xAging
606   $aSelegiline
615  0$aDepression, Mental.
615  0$aBrain$xAging.
615  0$aSelegiline.
676   $a616.8527
700   $aKnoll$b J$g(Jozsef)$097889
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910966526703321
996   $aHow selegiline ((-)-deprenyl) slows brain aging$94344175
997   $aUNINA